+44 (0)1223 839557
info@rxcelerate.com
ABOUT
VISION & MISSION
OUR STORY
LEADERSHIP
CAREERS
HOW WE HIRE
CURRENT VACANCIES
CAPABILITIES
BIOLOGY
IN VITRO
IN VIVO
SYSTEMS BIOLOGY
TRANSLATIONAL BIOMARKERS
MICROSCOPY
CHEMISTRY
In Silico Molecular Modelling
Medicinal Chemistry
Process & Scale Up
BIOANALYTICAL
PROGRAMME DESIGN & MANAGEMENT
GxP
THERAPEUTIC AREAS
MEDIA
RxCAPITAL
LICENCES & AFFILIATIONS
CONTACT
RxCelerate launch Galaxy™: a next-generation antibody discovery platform
Leading UK drug developer RxCelerate opens first US base in Boston
RxCelerate acquires Total Scientific Ltd
RxCelerate acquires The Cambridge Partnership Ltd
RxCelerate Opens UK-Based Chemistry Operations
RxCelerate acquires Prosarix
RxCelerate Expands
IMMUNOLOGY & INFLAMMATION
NEUROSCIENCE
ONCOLOGY
1
2
Next
Menu